Listening to the patient perspective is an ongoing trend in research and development. However, these efforts sometimes fail to lead to positive impacts when it comes to patient outcomes. Key challenges include only considering patient perspectives late in the drug development pipeline, focusing on a select number of patients, and failing to listen to what patients really want.
“We’ve seen the conversation around patient engagement accelerate hugely over the past decade, from a place of uncertainty to a minimum expectation at so many levels. The next step, we hope, will see this become more systematic and authentic on the continual journey towards value-driven healthcare.” Read more here.
(Source: Jo Fearnhead-Wymbs, PMLive, 9/13/21)
